Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DAND5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | C19orf48 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | KCNN3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | C1D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | CLEC14A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | RP11-451G4.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | VKORC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | F7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ST6GAL1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | SLC39A3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |